- $25.51m
- $151.41m
- CNY12.56bn
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | n/a | ||
| Price to Tang. Book | n/a | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 0.02 | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -24.95% | ||
| Return on Equity | n/a | ||
| Operating Margin | -0.44% | ||
Financial Summary
| Year End 31st Dec | Unit | 2021 | 2022 | 2023 | 2024 | 2025 | 2026E | 2027E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | CNYm | 12,425.9 | 13,516.7 | 14,948.13 | 14,401.25 | 12,556.02 | 18,190 | 20,884 | 8.89% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
111 Inc is an investment holding company primarily engaged in the operation of integrated online and offline healthcare platform. The Company mainly operates its business through two segments. The Business to Customer (B2C) segment is engaged in the sale of pharmaceutical and other health and wellness products through 1 Medicine Marketplace, mobile apps, other online channels and offline pharmacies to consumers and certain enterprise customers. The Business to Business (B2B) segment is engaged in the sale of pharmaceutical products to pharmacies on 1 Pharmacy. The Company also provides customers with online consultation and electronic prescription services through the Internet hospital 1 Clinic. The Company’s products include drugs, nutritional supplements, medical supplies and devices and other products. The Company mainly conducts its business in the domestic market.
Directors
- Gang Yu CCH (67)
- Junling Liu CCH (61)
- Nee Chuan Teo IND (55)
- Jian Sun IND (61)
- Jun Luo IND (59)
- Yang Chen DRC (56)
- Last Annual
- December 31st, 2025
- Last Interim
- June 30th, 2026
- Incorporated
- May 1st, 2013
- Public Since
- September 12th, 2018
- No. of Employees
- 1,063
- Sector
- Software & IT Services
- Industry
- Technology
- Exchange
NASDAQ Global Market- Shares in Issue
- 175,939,278
- Address
- 3-4/F, SHANGHAI, 201203
- Web
- http://corporate.111.com.cn/
- Phone
- +86 2120536666
- Auditors
- GRANT THORNTON ZHITONG CERTIFIED PUBLIC ACCOUNTANTS LLP
Latest News for YI
Upcoming Events for YI
Q3 2026 111 Inc Earnings Release
Q4 2026 111 Inc Earnings Release
Similar to YI
1stdibs.com
NASDAQ Global Market
9F
NASDAQ Global Market
Advasa Holdings
NASDAQ Global Market
Aiai Holdings
NASDAQ Global Market
Airship AI Holdings
NASDAQ Global Market
FAQ
As of Today at 18:00 UTC, shares in 111 are trading at $2.90. This share price information is delayed by 15 minutes.
Shares in 111 last closed at $2.90 and the price had moved by -32.4% over the past 365 days. In terms of relative price strength the 111 share price has underperformed the S&P500 Index by -38.34% over the past year.
The overall consensus recommendation for 111 is Strong Buy. You can view the full broker recommendation list by unlocking its StockReport.
Find out more111 does not currently pay a dividend.
111 does not currently pay a dividend.
111 does not currently pay a dividend.
To buy shares in 111 you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of $2.90, shares in 111 had a market capitalisation of $25.51m.
Here are the trading details for 111:
- Country of listing: United States
- Exchange: NMQ
- Ticker Symbol: YI
Based on an overall assessment of its quality, value and momentum 111 is currently classified as a Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
The analyst consensus target price for shares in 111 is $6.17. That is 112.75% above the last closing price of $2.90.
Analysts covering 111 currently have a consensus Earnings Per Share (EPS) forecast of for the next financial year.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like 111. Over the past six months, its share price has underperformed the S&P500 Index by -51.83%.
As of the last closing price of $2.90, shares in 111 were trading -42.23% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The 111 PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at $2.90.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
111's management team is headed by:
- Gang Yu - CCH
- Junling Liu - CCH
- Nee Chuan Teo - IND
- Jian Sun - IND
- Jun Luo - IND
- Yang Chen - DRC